Vivek Kumar Kashyap

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Meena Jaggi · 4 shared papers, 2018–2022 · strength 0.38
   • Paper Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore. DOI 10.1038/s42003-022-04102-4↗
   • Paper MUC13 contributes to rewiring of glucose metabolism in pancreatic cancer. DOI 10.1038/s41389-018-0031-0↗
   • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
2. Murali Mohan Yallapu · 4 shared papers, 2018–2022 · strength 0.38
   • Paper Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore. DOI 10.1038/s42003-022-04102-4↗
   • Paper MUC13 contributes to rewiring of glucose metabolism in pancreatic cancer. DOI 10.1038/s41389-018-0031-0↗
   • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
3. Sonam Kumari · 4 shared papers, 2018–2022 · strength 0.38
   • Paper Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore. DOI 10.1038/s42003-022-04102-4↗
   • Paper MUC13 contributes to rewiring of glucose metabolism in pancreatic cancer. DOI 10.1038/s41389-018-0031-0↗
   • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
4. Subhash C. Chauhan · 4 shared papers, 2018–2022 · strength 0.38
   • Paper Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore. DOI 10.1038/s42003-022-04102-4↗
   • Paper MUC13 contributes to rewiring of glucose metabolism in pancreatic cancer. DOI 10.1038/s41389-018-0031-0↗
   • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
5. Sheema Khan · 3 shared papers, 2018–2022 · strength 0.30
   • Paper Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore. DOI 10.1038/s42003-022-04102-4↗
   • Paper MUC13 contributes to rewiring of glucose metabolism in pancreatic cancer. DOI 10.1038/s41389-018-0031-0↗
   • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
6. Bilal Bin Hafeez · 3 shared papers, 2019–2022 · strength 0.29
   • Paper Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore. DOI 10.1038/s42003-022-04102-4↗
   • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
   • Paper Therapeutic efficacy of a novel βIII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer. DOI 10.1186/s13046-018-1009-7↗
7. Mohammed Sikander · 2 shared papers, 2019–2022 · strength 0.21
   • Paper Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore. DOI 10.1038/s42003-022-04102-4↗
   • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
8. Neeraj Chauhan · 2 shared papers, 2019 · strength 0.17
   • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
   • Paper Therapeutic efficacy of a novel βIII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer. DOI 10.1186/s13046-018-1009-7↗
9. Saini Setua · 2 shared papers, 2019 · strength 0.17
   • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
   • Paper Therapeutic efficacy of a novel βIII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer. DOI 10.1186/s13046-018-1009-7↗
10. Mehdi Chaib · 1 shared paper, 2022 · strength 0.13
    • Paper Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore. DOI 10.1038/s42003-022-04102-4↗
11. Stephen W. Behrman · 1 shared paper, 2022 · strength 0.13
    • Paper Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore. DOI 10.1038/s42003-022-04102-4↗
12. Subash C. Gupta · 1 shared paper, 2018 · strength 0.09
    • Paper MUC13 contributes to rewiring of glucose metabolism in pancreatic cancer. DOI 10.1038/s41389-018-0031-0↗
13. Andrew E. Massey · 1 shared paper, 2019 · strength 0.08
    • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
14. Advait B. Shetty · 1 shared paper, 2019 · strength 0.08
    • Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
15. Wěi Li · 1 shared paper, 2019 · strength 0.08
    • Paper Therapeutic efficacy of a novel βIII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer. DOI 10.1186/s13046-018-1009-7↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.